MedTrace Logo

Addiction Health Evaluation And Disease Management (AHEAD) Study

NCT00278447 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 569

Last updated 2014-10-02

No results posted yet for this study

Summary

The objective of this study is to test whether a chronic disease management (CDM) program for substance abusers in primary care leads to improved alcohol and drug-related outcomes (such as reduced consumption and health problems) and health care utilization patterns.

Conditions

  • Alcohol Dependence
  • Alcoholism
  • Drug Dependence

Interventions

BEHAVIORAL

Chronic Disease Management for substance abuse

Referral to primary medical care \& longitudinal, multidisciplinary care for persons with substance dependence.

BEHAVIORAL

Standard care

Referral to primary medical care for persons with substance dependence.

Sponsors & Collaborators

  • National Institute on Alcohol Abuse and Alcoholism (NIAAA)

    collaborator NIH

  • Boston Medical Center

    lead OTHER

Principal Investigators

  • Richard Saitz, MD, MPH · Boston University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-04-30
Primary Completion
2010-01-31
Completion
2012-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00278447 on ClinicalTrials.gov